Pharmacotherapy of dry eye

Bibliography

• Dogru M, Tsubota K. Treatment of dry eyes. Dry eye disease. The clinician's guide to diagnosis and treatment. In: Asbell and Lemp, editors, Thieme Publishers, New York; 2007. p. 84-94
   Google Scholar
• Dogru M, Tsubota K. Sjogren's syndrome. Smolin and thoft's the cornea: scientific foundations and clinical practice. In: Foster SC, Azar DT, Dohlman CH, editors, Lippincott Williams and Wilkins, Philadelphia; 2005. p. 629-47
   Google Scholar
• Pflugfelder S, Geerling G, Kinoshita S, Management and therapy of dry eye disease: report of the management and therapy subcommittee of the international dry eye workshop (2007). Ocul Surf 2007;5:163-78
   PubMed Web of Science ®Google Scholar
• Calonge M. The treatment of dry eye. Surv Ophthalmol 2001;45:227-39
   PubMed Web of Science ®Google Scholar
• Tsubota K, Yamada M. Tear evaporation from the ocular surface. Invest Ophthalmol Vis Sci 1992;33:2942-50
   PubMed Web of Science ®Google Scholar
• Shimmura S, Goto E, Shimazaki J, Tsubota K. Viscosity-dependent fluid dynamics of eyedrops on the ocular surface. Am J Ophthalmol 1998;125:386-8
   PubMed Web of Science ®Google Scholar
• Lerner LE, Schwartz DM, Hwang DG, Hyaluronan and CD44 in the human cornea and limbal conjunctiva. Exp Eye Res 1998;67:481-4
   PubMed Web of Science ®Google Scholar
• Baudouin F, Brignole F, Dupas B, Reduction in keratitis and CD44 expression in dry eye patients treated with a unique 0.18% sodium hyaluronate solution(abstract 180). (ARVO abstract). Invest Ophthalmol Vis Sci 2001;42:S32
   Web of Science ®Google Scholar
• Entwistle J, Hall CL, Turley EA. HA receptors: regulators of signalling to the cytoskeleton. J Cell Biochem 1996;61:569-77
   PubMed Web of Science ®Google Scholar
• Stern ME, Beuerman RW, Fox RI, The pathology of dry eye: the interaction between the ocular surface and lacrimal gland. Cornea 1998;17:584-9
   PubMed Web of Science ®Google Scholar
• Aragona P, Di Stefano G, Ferreri F, Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjogren's syndrome patients. Br J Ophthalmol 2002;86:879-84
   PubMed Web of Science ®Google Scholar
• Condon PI, McEwen CG, Wright M, Double blind, randomized, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome. Br J Ophthalmol 1999;83:1121-4
   PubMed Web of Science ®Google Scholar
• Avisar R, Robinson A, Appel I, Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis. Cornea 2000;19:145-7
   PubMed Web of Science ®Google Scholar
• Aragona P, Stilo A, Ferreri F, Mobrici M. Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjogren's syndrome patients. Eye 2005;19:535-9
   PubMed Web of Science ®Google Scholar
• Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The cyclosporin A Phase 2 study group. Ophthalmology 2000;107:967-74
   PubMed Web of Science ®Google Scholar
• Sall K, Stevenson OD, Mundorf TK, Two multicenter, randomized studies of the efficacy and safety of cyclosporin ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 study group. Ophthalmology 2000;107:631-9
   PubMed Web of Science ®Google Scholar
• Toker E, Asfuroglu E. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporin therapy. Cornea 2010;29:133-40
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, De Paiva CS, Villarreal AL, Stern ME. Effects of sequential artificial tear and cyclosporin emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production. Cornea 2008;27:64-9
   PubMed Web of Science ®Google Scholar
• Brignole F, Pisella PJ, De Saint Jean M, Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci 2001;42:90-5
   PubMed Web of Science ®Google Scholar
• Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol 2003;136:593-602
   PubMed Web of Science ®Google Scholar
• Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology 1999;106:811-16
   PubMed Web of Science ®Google Scholar
• Worda C, Nepp J, Huber JC, Sator MO. Treatment of keratoconjunctivitis sicca with topical androgen. Maturitas 2001;37:209-12
   PubMed Web of Science ®Google Scholar
• Sator MO, Joura EA, Golaszewski T, Treatment of menopausal keratoconjunctivitis sicca with topical oestradiol. Br J Obstet Gynaecol 1998;105:100-2
   PubMedGoogle Scholar
• Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med Biol 2002;506(Pt B):989-98
   PubMedGoogle Scholar
• Miljanovic B, Trivedi KA, Dana MR, Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr 2005;82(4):887-93
   PubMed Web of Science ®Google Scholar
• Barabino S, Rolando M, Camicione P, Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea 2003;22:97-101
   PubMed Web of Science ®Google Scholar
• Aronowicz JD, Shine WE, Oral D, Short term oral minocycline treatment of meibomianitis. Br J Ophthalmol 2006;90:856-60
   PubMed Web of Science ®Google Scholar
• Frucht-Pery J, Sagi E, Hemo I, Ever-Hadani P. Efficacy of doxycycline and tetracycline in ocular rosacea. Am J Ophthalmol 1993;116:88-92
   PubMed Web of Science ®Google Scholar
• Yoo SE, Lee DC, Chang MH. The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean J Ophthalmol 2005;19:258-63
   PubMedGoogle Scholar
• Matsumoto Y, Shigeno Y, Sato EA, The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy. Graefes Arch Clin Exp Ophthalmol 2009;247:821-9
   PubMed Web of Science ®Google Scholar
• Ferraccioli GF, Salaffi F, De Vita S, Interferon alpha-2 (IFN alpha 2. increases lacrimal and salivary function in Sjogren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine. Clin Exp Rheumatol 1996;14:367-71
   PubMed Web of Science ®Google Scholar
• Lee SJ, Vogelsang G, Gilman A, A survey of diagnosis, management and grading of chronic graft versus host disease. Biol Blood Bone Marrow Transplant 2002;8:32-9
   PubMed Web of Science ®Google Scholar
• Jackson RS II, Van Dyken SJ, McCartney MD, The eicosanoid, 15-(S)-HETE, stimulates secretion of mucin-like glycoprotein by the corneal epithelium. Cornea 2001;20:516-21
   PubMed Web of Science ®Google Scholar
• Kobayashi TK, Tsubota K, Takamura E, Effect of retinol palmitate as a treatment for dry eye: a cytological evaluation. Ophthalmologica 1997;211:358-61
   PubMed Web of Science ®Google Scholar
• Shigemitsu T, Shimizu Y, Doi K, Clinical evaluation of mucin ophthalmic solution on dry eye. Cornea 2000;19:S122
   Google Scholar
• Vivino FB, Al-Hashimi I, Khan Z, Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med 1999;159:174-81
   PubMed Web of Science ®Google Scholar
• Petrone D, Condemi JJ, Fife R, A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 2002;46:748-54
   PubMed Web of Science ®Google Scholar
• Fox R, Chan R, Michelson J, Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984;27:459-61
   PubMed Web of Science ®Google Scholar
• Tsubota K, Goto E, Fujita H, Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 1999;83:390-5
   PubMed Web of Science ®Google Scholar
• Speek AJ, van Agtmaal EG, Saowakontha S, Fluorometric determination of retinal of human tear fluid using high-performance liquid chromatography. Curr Eye Res 1986;5:841-5
   PubMed Web of Science ®Google Scholar
• Danjo Y, Hamano T. Observation of precorneal tear film in patients with Sjogren's syndrome. Acta Ophthalmol Scand 1995;73:501-5
   PubMedGoogle Scholar
• Kojima T, Ishida R, Dogru M, The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 2005;139:242-6
   PubMed Web of Science ®Google Scholar
• Noble BA, Loh RS, MacLennan S, Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004;88:647-52
   PubMed Web of Science ®Google Scholar
• Kijlstra A, Jeurissen SH, Koning KM. Lactoferrin levels in normal human tears. Br J Ophthalmol 1983;67:199-202
   PubMed Web of Science ®Google Scholar
• Sen DK, Sarin GS. Immunoglobulin concentrations in human tears in ocular diseases. Br J Ophthalmol 1979;63:297-300
   PubMed Web of Science ®Google Scholar
• Shimmura S, Ueno R, Matsumoto Y, Albumin as a tear supplement in the treatment of severe dry eye. Br J Ophthalmol 2003;87:1279-83
   PubMed Web of Science ®Google Scholar
• Geerling G, Hartwig D. Autologous serum eye drops for ocular surface disorders. Essentials of ophthalmology: cornea and external eye disease. In: Reinhard T, Larkin DFP, editors, Springer, Berlin; 2006. p. 2-18
   Google Scholar
• Tsubota K, Monden Y, Yagi Y, New treatment of dry eye: the effect of calcium ointment through eyelid skin delivery. Br J Ophthalmol 1999;83:767-70
   PubMed Web of Science ®Google Scholar
• Holly FJ. Tear film physiology. Am J Optom Physiol Opt 1980;57:252-7
   PubMedGoogle Scholar
• Tiffany JM. The role of meibomian secretion in the tears. Trans Ophthalmol Soc UK 1985;104:396-401
   PubMedGoogle Scholar
• Tiffany JM. The lipid secretion of the meibomian glands. Adv Lipis Res 1987;22:1-62
   PubMedGoogle Scholar
• Mitsui T. Physiochemistry of the Cosmetics. 1st edition. Nanzando, Tokyo: 1993. p. 128-56
   Google Scholar
• Nagai K. Polyoxyethylene castor oil derivatives. Handbook of Pharmaceutical Excipients, In: Saito Y, editor, Japanese Edition. The Pharmaceutical Society of Japan, Tokyo; 1986. p. 345-8
   Google Scholar
• Goto E, Shimazaki J, Monden Y, Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction. Ophthalmology 2002;109:2030-5
   PubMed Web of Science ®Google Scholar
• Gogia R, Richer SP, Rose RC. Tear fluid content of electrochemically active components including water soluble antioxidants. Curr Eye Res 1998;17:257-63
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Dogru M, Tsubota K. Laboratory findings in tear fluid analysis. Clin Chim Acta 2006;369:17-28
   PubMed Web of Science ®Google Scholar
• Kuizenga A, van Haeringen NJ, Kijlstra A. Inhibition of hydroxyl radical formation by human tears. Invest Ophthalmol Vis Sci 1987;28:305-13
   PubMed Web of Science ®Google Scholar
• Dogru M, Matsumoto Y, Yamamoto Y, Lactoferrin in Sjogren's syndrome. Ophthalmology 2007;114:2366-7
   PubMed Web of Science ®Google Scholar